Daiichi Sankyo UK Ltd is a UK affiliate company with corporate origins in Japan. We create and supply innovative products to help the NHS deliver patient care in the fields of cardiovascular disease and oncology.
Our company was founded in 2006 through the merger of the well-established Japanese companies Daiichi and Sankyo in Europe. Daiichi Sankyo is a global pharmaceutical company based in Japan that has a presence in more than 30 countries around the world. With a legacy of innovation since 1899, we are the pioneer behind leading pharmaceuticals that have contributed to enrich the quality of life around the world.
Our global headquarters is in Tokyo. We have 16 affiliates in Europe and Canada with about 3,000 employees. Our European headquarters is in Munich, Germany, and not far from there, one of our global production plants is located in Pfaffenhofen an der Ilm.
European Structure
Daiichi Sankyo Europe GmbH is a wholly owned affiliate of Daiichi Sankyo Co., Ltd., headquartered in Tokyo. It is a limited liability company under German corporate law. Our company's Managing Director is Masahiro Kato.
Our national European and Canadian organisations are affiliates of Daiichi Sankyo Europe GmbH and have their offices in the individual countries. The Supervisory Board of Daiichi Sankyo Europe GmbH is headed by Chairman Ryotaro Tanaka.
UK/DSC/06/26/0012 - June 2026
